Treffer 1 - 2 von 2 für Suche 'Cho, Byoung Chun John', Suchdauer: 0,37s Treffer weiter einschränken
  1. 1

    Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study von Garassino, Marina Chiara, Kim, Joo-Hang, Corral Jaime, Jesus, Powderly, John, Bidoli, Paolo, Wheatley-Price, Paul, Park, Keunchil, Wadsworth, Catherine, Dennis, Phillip A, Rizvi, Naiyer A, Paz-Ares Rodriguez, Luis, Novello, Silvia, Hiret, Sandrine, Schmid, Peter, Laack, Eckart, Califano, Raffaele, Vicente Baz, David, Berghmans, Thierry, Kim, Dong-Wan, Surmont, Veerle, Reck, Martin, Han, Ji-Youn, Holgado Martin, Esther, Chella, Antonio, Chopra, Akhil, Robinet, Gilles, Soto Parra, Hector, Thomas, Michael, Katakami, Nobuyuki, Su, Wu-Chou, Kim, Young-Chul, Lee, Jong-Seok, Saka, Hideo, Milella, Michele, Ramos Garcia, Inmaculada, Sibille, Anne, Atagi, Shinji, Spaeth-Schwalbe, Ernst, Nishio, Makoto, Imamura, Fumio, Derijcke, Sofie, Maeda, Tadashi, Zylla, Dylan, Santoro, Armando, Uy, Ma. Noemi, Lucien Geater, Sarayut, Kowalski, Dariusz, Chen, Yuh-Min, Spigel, David, Chewaskulyong, Busyamas, Garcia Gomez, Ramon, Alvarez Alvarez, Rosa, Yang, Chih-Hsin, Denis, Fabrice, Sakai, Hiroshi, Canon, Jean-Luc, Scholz, Christian, Kemmotsu, Hirotsugu, Azuma, Koichi, Feld, Ronald, Jassem, Jacek, Kubota, Kaoru, Waterhouse, David, Coudert, Bruno, Mark, Zsuzsanna, Chang, Gee-Chen, Herzmann, Christian, Chaudhry, Arvind, Giridharan, Selvaraj, Hesketh, Paul, Boccia, Ralph, Iannotti, Nichola, Haigentz, Missak, Reynolds, John, Nakagawa, Kazuhiko, Sugawara, Shunichi, Tan, Eng Huat, Takeda, Koji, Mohn-Staudner, Andrea, Panwalkar, Amit, Daniel, Davey, Kobayashi, Kunihiko, Ladrera, Guia Elena Imelda, Coupkova, Helena, Havel, Libor, Singh, Joginder, Murakami, Shuji, Anderson, Ian, Iqbal, Mussawar, Torri, Vamsee, Juhasz, Erzsebet, Koubkova, Leona, Levy, Benjamin, Page, Ray, Crinò, Lucio, Einspahr, David, Hagenstad, Christopher, Juat, Necy, Overton, Lindsay, Szalai, Zsuzsanna

    Veröffentlicht in The lancet oncology

    Volltext
    Artikel
  2. 2